| Literature DB >> 36186226 |
Yudai Tateishi1, Katsuyuki Sakanaka1, Hideaki Hirashima1, Nobutaka Mukumoto1, Hiroyuki Inoo1, Kota Fujii1, Tomohiro Ono1, Mitsuhiro Nakamura2, Manabu Nakata3, Kaoru Kawasaki4, Hirohiko Tani4, Masaki Mandai4, Takashi Mizowaki1.
Abstract
The information of definitive radiotherapy for a pregnant woman with malignancy was limited; however, it was reported to be potentially feasible with minimal risks. We performed definitive chemoradiotherapy for a pregnant woman with locally advanced cervical esophageal cancer. Feasibility of radiotherapy and safety of fetus were confirmed by the phantom study estimating fetal dose, and monitoring it in each radiotherapy session. The planned chemoradiotherapy completely eradicated esophageal cancer while preserving her laryngopharyngeal function. A female infant was delivered by cesarian section after planned chemoradiotherapy, and she grew without any apparent disorders 2 years after chemoradiotherapy. Chemoradiotherapy might be one of the treatment options for a pregnant woman with cervical esophageal cancer especially wishing the preservation of laryngopharyngeal function.Entities:
Keywords: Chemotherapy; Esophageal cancer; Pregnancy; Radiotherapy
Year: 2022 PMID: 36186226 PMCID: PMC9522944 DOI: 10.1007/s13691-022-00564-9
Source DB: PubMed Journal: Int Cancer Conf J ISSN: 2192-3183